1. Home
  2. RNXT vs ZCMD Comparison

RNXT vs ZCMD Comparison

Compare RNXT & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • ZCMD
  • Stock Information
  • Founded
  • RNXT 2012
  • ZCMD 2012
  • Country
  • RNXT United States
  • ZCMD China
  • Employees
  • RNXT N/A
  • ZCMD N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • ZCMD Other Consumer Services
  • Sector
  • RNXT Health Care
  • ZCMD Real Estate
  • Exchange
  • RNXT Nasdaq
  • ZCMD Nasdaq
  • Market Cap
  • RNXT 31.6M
  • ZCMD 35.3M
  • IPO Year
  • RNXT 2021
  • ZCMD 2020
  • Fundamental
  • Price
  • RNXT $1.16
  • ZCMD $1.40
  • Analyst Decision
  • RNXT Strong Buy
  • ZCMD
  • Analyst Count
  • RNXT 1
  • ZCMD 0
  • Target Price
  • RNXT $9.00
  • ZCMD N/A
  • AVG Volume (30 Days)
  • RNXT 202.5K
  • ZCMD 6.1K
  • Earning Date
  • RNXT 03-31-2025
  • ZCMD 01-01-0001
  • Dividend Yield
  • RNXT N/A
  • ZCMD N/A
  • EPS Growth
  • RNXT N/A
  • ZCMD N/A
  • EPS
  • RNXT N/A
  • ZCMD N/A
  • Revenue
  • RNXT N/A
  • ZCMD $17,406,104.00
  • Revenue This Year
  • RNXT N/A
  • ZCMD N/A
  • Revenue Next Year
  • RNXT N/A
  • ZCMD N/A
  • P/E Ratio
  • RNXT N/A
  • ZCMD N/A
  • Revenue Growth
  • RNXT N/A
  • ZCMD 1.01
  • 52 Week Low
  • RNXT $0.77
  • ZCMD $1.00
  • 52 Week High
  • RNXT $1.86
  • ZCMD $5.10
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 35.18
  • ZCMD 41.35
  • Support Level
  • RNXT $1.32
  • ZCMD $1.36
  • Resistance Level
  • RNXT $1.40
  • ZCMD $1.51
  • Average True Range (ATR)
  • RNXT 0.09
  • ZCMD 0.09
  • MACD
  • RNXT -0.04
  • ZCMD 0.00
  • Stochastic Oscillator
  • RNXT 4.88
  • ZCMD 20.69

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About ZCMD Zhongchao Inc.

ZHONGCHAO Inc is a Cayman Islands-based provider of healthcare information, education, and training services. It provides services to healthcare professionals and the public in China. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting of clinical practice training, open classes of popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content.

Share on Social Networks: